Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.
Two classes of structurally different tachykinin neurokinin3 (NK3) antagonists were used to evaluate species difference in antagonist binding between human and rat NK3 receptors. In competition binding experiments with [125I-MePhe7]NKB as radioligand, PD 154740, PD 157672, SR 48968, and SR 142801 displayed lower Ki values for the human NK3 receptor (40 +/- 4, 12 +/- 1,350 +/- 50, and 0.40 +/- 0.05 nM, respectively) than for the rat NK3 receptor (2450 +/- 130, 288 +/- 25, > 10,000, and 11.0 +/- 0.5 nM, respectively). Data from in vitro functional assay showed similar species preference as observed with the competition binding assay. It was shown previously that substitution of only two amino acid residues in the rat receptor to their human counterparts could change the species selectivity of SR 48968, a weak NK3 antagonist. In the double-substituted rat mutant, all three antagonists (PD 154740, PD 157672, and SR 142801) displayed Ki values (76 +/- 8, 16 +/- 2, and 0.50 +/- 0.05 nM, respectively) very similar to the Ki values for the wild-type human NK3 receptor. Thus, in addition to their previously reported effects on SR 48968, these two amino acid residues are responsible for the species selectivity of these three additional NK3 antagonists. Because PD 154740 and PD 157672 are very different structurally from SR 48968 and SR 142801, our results indicate that the two identified residues may be involved in adopting a receptor conformation that favors the binding of NK3 antagonists that display species preference for the human NK3 receptor.
D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001667:Binding, Competitive; D016466:CHO Cells / Q000378:metabolism / Q000648:ultrastructure; D006224:Cricetinae; D004151:Dipeptides / Q000494:pharmacology; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D007457:Iodine Radioisotopes; D007700:Kinetics; D009154:Mutation; D015287:Neurokinin B / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D010649:Phenylalanine / Q000031:analogs & derivatives / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011869:Radioligand Assay; D051381:Rats; D018042:Receptors, Neurokinin-3 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013045:Species Specificity; D013329:Structure-Activity Relationship
D001549:Benzamides; D004151:Dipeptides; D007295:Inositol Phosphates; D007457:Iodine Radioisotopes; D010880:Piperidines; D018042:Receptors, Neurokinin-3; C080394:neurokinin B, MePhe(7)-; C096332:PD 154740; C096333:PD 157672; D010649:Phenylalanine; C073839:SR 48968; D015287:Neurokinin B; C091554:SR 142801